“Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance”, J. Can. Res. Updates, vol. 2, no. 4, pp.  306–317, Nov. 2013, doi: 10.6000/1929-2279.2013.02.04.9.